
Sign up to save your podcasts
Or


00:04 — Introduction & Episode Overview
01:44 — Today’s Financial Environment
02:26 — Bringing Discipline to Capital Equipment Planning
03:17 — Post-COVID Capital Decisions & Embedded Leases
04:02 — The “Spiderweb” of Placement Agreements
05:02 — The Need for Specialized Expertise
06:25 — Capital Equipment as a Growing Strategic Priority
08:01 — Balancing Immediate Needs With Long-Term Strategy
09:28 — The Visibility Problem
10:09 — CapEx, OpEx & Hidden Equipment Costs
11:57 — When Keeping Aging Equipment Costs More Than Replacing It
13:07 — Cybersecurity, Maintenance & Operational Risk
14:55 — The Long-Term Cost of Deferring Capital Decisions
16:26 — Connecting Capital Investment to Patient Care
18:08 — Creative Equipment Funding Models
20:44 — Avoiding Pressure-Driven Capital Decisions
21:12 — Hidden Financial & Strategic Risk
22:38 — Turning Equipment Into a Strategic Asset
24:30 — Capital Planning as a Competitive Advantage
26:08 — Best-in-Class Care Requires Best-in-Class Tools
26:57 — Capital Planning Trends Over the Next 3–5 Years
28:52 — Moving Capital Equipment From Afterthought to Strategy
30:01 — Final Advice: Start With Visibility
Danny’s takeaway:
30:38 — Take Ownership of Capital Decisions
Jon’s takeaway:
31:03 — Closing
Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
Healthcare organizations often negotiate strong pricing, incentives and contract terms for capital equipment, but the full value of those agreements can be lost as projects move into execution. In this episode, we examine where value leakage occurs, why it can be difficult to detect and how Vizient’s Capital Procurement Recovery program helps healthcare organizations validate pricing, activate contract benefits and recover missed value while protecting every capital dollar invested.
Guests:
Vizient Capital Procurement Recovery subject matter experts
Capital Equipment Solutions and Contract Services
Vizient
Moderator:
Susan Edwards
Product Marketing Manager
Vizient
Show Notes:
[00:52 – 02:25] Why is protecting negotiated capital value increasingly important for healthcare organizations?
[02:25 – 04:35] How fragmented project teams and stakeholder handoffs create blind spots during capital procurement.
[04:35 – 06:30] The operational, clinical and financial effects of value leakage.
[06:30 – 08:40] Why margin pressure makes recovering every available capital dollar more important.
[08:40 – 10:40] The client challenge that led to the development of Capital Procurement Recovery.
[10:40 – 12:45] How missed pricing tiers, rebates and incentives can reduce the value of a negotiated agreement.
[12:45 – 14:50] The discovery process: validating purchases, contract terms and supplier commitments.
[14:50 – 16:55] The difference between a traditional vendor and a strategic capital procurement partner.
[16:55 – 18:55] How Vizient’s GPO relationships, contract knowledge and market perspective support recovery efforts.
[18:55 – 20:45] What the Capital Procurement Recovery review looks like in practice.
[20:45 – 22:35] The performance-based model and how it aligns success with measurable value delivered.
[22:35 – 24:20] Why active validation matters throughout the capital procurement lifecycle.
[24:20 – 26:08] Key takeaways: do not assume negotiated terms will be realized automatically, and use recovered value to support patient care, infrastructure and future growth.
Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
Today we're going to explore the current state of rural hospitals and independent community hospitals, many of which are navigating razor thin margins and rising capital costs. We'll talk about emerging policy support and how this may impact capital investment decisions.
Guests:
Russell Hall
VP, Independent Community Market
Vizient
Rebecca Gayden
Sr Principal, Capital Equipment Solutions
Vizient
Host:
Susan Edwards
Product Marketing Manager
Vizient
Show Notes:
[01:40 – 3:27] State of the union when it comes to rural hospitals
[03:27 – 04:09] The pressures being faced by rural and community hospitals and how that affects capital spend
[04:09 – 04:46] The tradeoffs being made
[04:46 – 6:27] How an independent hospital needs to prioritize
[6:27 – 8:22] Rural health transformation funds
[8:22 – 9:08] Following the money
[9:08 – 13:41] Determining eligibility and other options
[13:42 – 15:55] How we bridge the gap between strategy and action
[15:55 – 17:57] The most effective use of dollars
[17:57 – 19:10] Maximizing capital dollars
[19:10 – 20:47] Additional levers and Group buys
[20:47 – 24:11] What's ahead
[24:11 – 25:42] Wrap up and suggestions
Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
Haphazard plans aren't really plans at all and when you are dealing with capital commitments that can range from thousands to hundreds of thousands of dollars In expense, the work you do BEFORE you spend Is as Important as the spend Itself. That's where Capital Commit comes In.
Guests:
Mahogany Laur
Tammi Pegues
Host:
Susan Edwards
Show Notes:
[00:45 – 05:08] What Is the capital commit program? What Is the history of It?
[05:08 – 08:04] The power of aggregation and the Ideal client.
[08:04 – 09:20] Utilizing leverage and commitment.
[09:20 – 12:10] Group buys and how commit Is different.
[12:10 – 14:52] How does the program support the suppliers? The power of Data.
[14:52 – 15:46] Price paid transparency.
[15:46 – 20:32] What Is the future of Capital Commit?
[20:32 – 22:37] Wrap up and suggestions
Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
Where is the true value in capital equipment procurements? Capital purchases are often high-stakes decisions that require coordination between clinical, financial and operational teams. Listen In as we unlock the secrets to finding value within your capital expenditures.
Guest:
Adam Fairbourn
Sr. Director, Contract Services
Vizient
Joni Swartz
Sr. Director, Contract Services
Vizient
Host:
Susan Edwards
Product Marketing Manager
Vizient
Show Notes:
[01:24 – 03:05] What makes capital equipment procurement unique?
[03:05 – 05:30] Vizient's bid process explained.
[05:30 – 07:13] How important is the total cost of ownership?
[07:13 – 9:58] What value can be unlocked In the GPO national agreements.
[9:58 – 12:17] Examples of how the framework Is put together.
[12:17 – 13:39] What Is the value of unlocking a GPO?
[13:39 – 14:58] How can smaller clients unlock the same value?
[14:58 – 16:18] Are group buys available?
[16:18 – 19:10] Unlocking value on a large scale.
[19:10 – 21:45] Are there quick wins to be found?
[21:45 – 23:05] Wrap up and suggestions
Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
What makes medical equipment planning such a crucial part of the construction, expansion and renovation equation? When you think of construction costs, you can't limit yourself to thinking of bricks and drywall. There's way more to It. In this episode, we explore the costs associated with medical equipment and medical equipment planning so that you're better Informed when It comes time to renovate or build that new medical space.
Guest:
Patrick Melone
Associate Principal, Capital Equipment Solutions
Vizient
Host:
Susan Edwards
Product Marketing Manager
Vizient
Show Notes:
[00:52 – 02:21] What's the big picture? Why Is medical equipment planning Important?
[02:30 – 03:30] The hidden pitfalls of construction and expansion projects.
[03:31 – 04:50] How do you now need to approach equipment planning with new developments in technology?
[04:51 – 7:27] How does cyber security play into planning?
[7:28 – 9:10] Where can cost overruns happen?
[9:20 –10:45] The lifecycle of equipment. The total cost of ownership.
[10:47 – 11:29] The Importance of terms and conditions.
[11:27 – 12:24] Is sustainability a key decision-making element?
[12:24 – 14:17] The Vizient difference. The value of the GPO.
[14:17 – 16:34] How do we get a project to the finish line?
[16:34 – 18:02] Budget management.
[18:02 – 19:09] The role of medical equipment planning during the construction process.
[19:09 – 19:56] The owner contractor architect meeting.
[19:56 – 21:17] Key takeaways and things to think about.
[21:17 – 22:15] Wrap up and suggestions
Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
What is the true cost of ownership when it comes to medical equipment? When you think of capital spending, ownership costs can become very configurable from the standpoint that everyone has different systems, tools and methods to arrive at a base value. That's why Vizient has put tools in place that allow for a certain amount of standardization and consistency, essentially leveling the field when it comes to ownership costs and strategies.
Guest:
Danny Cisneros
Sr. Consulting Director
Vizient
Host:
Susan Edwards
Product Marketing Manager
Vizient
Show Notes:
[00:46 – 03:15] What Is total cost of ownership? What Is Its history?
[03:15 – 04:13] The science behind "unbundling" of equipment costs
[04:13 – 08:20] How does the cost of ownership Impact expansion?
[08:20 – 10:22] The approach to consolidating people and resources
[10:22 – 12:28] Unbundling and the lifecycle of equipment
[12:28 – 13:44] Finding the hidden costs and working over time
[13:44 – 15:27] Assets advice for organizations
[15:27 – 16:22] Balancing needs and outcomes for the ASC's
[16:22 – 19:07] Real life examples and how to respond
[19:07 – 21:15] Does everyone face the same challenges and what Is It about capital equipment that adds to the complexity of the Issue?
[21:15 – 22:12] Terminology
[22:12 – 23:44] Wrap up and suggestions
Links | Resources:
CES Case Studies
Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
Whether you're navigating decentralized purchasing, benchmarking spend, or trying to align capital budget system wide, the Capital Spend Insights tool was built to transform how your organization approaches capital planning. Mike Kolp, associate principal from Vizient's Capital Equipment Solutions team joins host Susan Edwards to share how health systems are using Capital Spend Insights to unlock smarter, faster and more strategic decisions.
Guests:
Mike Kolp,
Associate Principal, Vizient Capital Equipment Solutions
Vizient
Moderator:
Susan Edwards
Marketing Communications Manager
Show Notes:
[01:09 – 02:04] The why behind Capital Spin Insights
[02:05 – 03:15] Industry overarching trends needing solutions for capital provurement
[03:16 – 03:59] How capital spend insights tool changes visibility traditionally exposed in the capital procurement process
[04:00 – 05:11] How Capital Spend Insights make the quote review process better
[05:12 – 07:37] Comparing Capital Spend Insights to what's available in the marketplace from other competitors
[07:38 – 10:22] How Capital Spend Insights works alongside or in tandem with the other Vizient data solutions
[10:45 – 11:36] How full fledged subscribers are they using the tool most effectively in their organizations today
[11:37 – 13:00] Common types of projects that got clients interested in using this tool
[13:01 – 17:09] The tool’s GPO compliance component and the pull through of budget alignments
[17:10 – 19:03] New improvements and enhancements for the solution
[19:04 – 20:41] Comparing Capital Spend Insights to key Competitors
[20:42 – 23:25] Key Takaways
[23:26 – 24:19] Next steps for people interested in the tool
[24:20 – 25:08] Mike will be talking about the tool at the Vizient Summit
Links | Resources:
Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
Theranostics is a groundbreaking topic that's reshaping how we diagnose and treat cancer. It's a cutting-edge approach in cancer care, combining diagnosing and treating cancer using the same molecular tools. Theranostics has the spotlight because it's delivering on a promise we've been chasing for years in cancer care, truly personalized targeted treatment with fewer side effects than traditional options.
Guests:
Lindsay Williams, MBA, CNMT, R.T.(N)(CT)(ARRT)
Pharmacy Sourcing Portfolio Executive
Vizient
Setu Shah, MPH
Sr. Associate, Intelligence
Sg2
Janna Laton, MBA, CNMT, NMTCB(CT), R.T.(R)(N)(MR)(ARRT)
Independent Contributor and SME
Host:
Adam Fairbourn, MBA, CNMT
Senior Director, Contract Services
Vizient, Capital Equipment Solutions
Show Notes:
[00:48 – 01:55] What it takes for a healthcare organization to implement Theranostics
[01:56 – 04:04] Success stories solving for some of the access and workflow issues
[04:05 – 05:11] Education and training programs needed to support demand for nuclear medicine specialists and technologists
[05:12 – 07:54] What's driving that growth in the field
[07:55 – 09:34] What’s most exciting about theranostics over the next five to 10 years
[09:34– 10:08] Will Theranostics become the standard of care for more types of cancer than we see today
[10:09 – 11:30] The future of cancer care and Theranostics
[11:30– 12:03] What Vizient is doing on the Theranostics front
Links | Resources:
Vizient article - https://www.vizientinc.com/insights/diagnostic-imaging
Sg2 Perspectives Podcast: Transforming Cancer Care Delivery
Sg2 Perspectives Podcast: Cell and Gene Therapy in Practice
Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
Theranostics is a groundbreaking topic that's reshaping how we diagnose and treat cancer. It's a cutting-edge approach in cancer care, combining diagnosing and treating cancer using the same molecular tools. Theranostics has the spotlight because it's delivering on a promise we've been chasing for years in cancer care, truly personalized targeted treatment with fewer side effects than traditional options.
Guests:
Lindsay Williams, MBA, CNMT, R.T.(N)(CT)(ARRT)
Pharmacy Sourcing Portfolio Executive
Vizient
Setu Shah, MPH
Sr. Associate, Intelligence
Sg2
Janna Laton, MBA, CNMT, NMTCB(CT), R.T.(R)(N)(MR)(ARRT)
Independent Contributor and SME
Host:
Adam Fairbourn, MBA, CNMT
Senior Director, Contract Services
Vizient, Capital Equipment Solutions
Show Notes:
[00:45] Defining Theranostics and why it’s getting attention
[02:10] “See what you treat and treat what you see” captures the power of Theranostics
[03:10] Why neuroendocrine tumors and prostate cancer are particularly well suited for this approach
[03:50] Prostate specific membrane antigen or PSMA targeted imaging and treatment work and results
[05:28] How Theranostics compares with more traditional cancer treatments in terms of precision and side effects
Links | Resources:
Vizient article - https://www.vizientinc.com/insights/diagnostic-imaging
Sg2 Perspectives Podcast: Transforming Cancer Care Delivery
Sg2 Perspectives Podcast: Cell and Gene Therapy in Practice
Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
From the publisher's feed